MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. Unique Pain Medicine.

Patients 52

Patients Treatment Clinical Trials Therapy 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Pain, anxiety and sleep issues are often interconnected – chronic pain can also cause mental health and sleep issues.”. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

MAY 3, 2022

The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. The team focused its efforts on understanding whether owning an MMJ card impacted CUD, particularly in terms of chronic pain, insomnia, anxiety, or depressive symptoms.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

The Joint Blog

FEBRUARY 11, 2022

The data from this study is promising and reveals that CBD worked to inhibit the spread of a virus in human lung cell samples, which is huge news. However, it warrants further examination and exploration by science in the form of clinical trials, which is what many in the scientific community are calling for.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Canna Care Docs

DECEMBER 16, 2020

The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Puff Puff Post

JANUARY 1, 2020

Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain. At other times cannabis treats the pain of cancer patients better. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

MAY 14, 2022

In addition to the regulatory barriers to access, funding has long been cited as a problem, with limited patient access through the UK’s National Health Service. Canpain is planned to run for three years and aims to conduct clinical trials involving up to 5,000 patients suffering from chronic pain.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Puff Puff Post

JANUARY 1, 2020

Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain. At other times cannabis treats the pain of cancer patients better. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Herb Collective

JUNE 3, 2018

Treats Chronic Pain Patients suffering from chronic pain have reported that CBD oil acts as a soothing agent. Its pathology can prevent nervous system degeneration which makes it a viable treatment option for patients suffering from diseases like fibromyalgia, multiple sclerosis, and Rheumatoid Arthritis.

Oil 56

Oil CBD Blood Pressure Chronic Pain 56

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

NOVEMBER 16, 2021

Believed to be the only IND application ever cleared by the FDA for a Phase 2 trial of a patented drug for delaying aging. Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Joint Blog

APRIL 17, 2020

Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g., Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Data To Support Regulatory Filings in the United States. a leading clinical trial services company, for a First in Human study investigating Epoladerm™ for pain associated with osteoarthritis of the knee. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Project CBD

FEBRUARY 27, 2023

No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression. Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life.

THC 144

THC CBD Sleep Clinical Trials 144

Project CBD

MAY 3, 2023

Goldstein has treated thousands of patients with medical cannabis. She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

The Cannigma

JANUARY 13, 2023

Chronic migraines can make it incredibly challenging to hold down a job. The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. In October 2021, Virpax announced that a $1.87 About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

The Cannigma

APRIL 8, 2021

So yeah, I spend my time helping physicians and nurses more than I do counting bills and talking to patients. Perhaps the patient turns out to be allergic to that medicine or whatnot. What I see is more of a bifurcated model where you have true medical patients. That means you work in a hospital?

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Pre-defined inclusion and exclusion criteria were applied uniformly.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. The states’ situation varies substantially.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 40

Programs Research and Development Education Treatment 40

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

AUGUST 30, 2019

The US Department of Agriculture (USDA) has released new data indicating a substantial increase in the growth of US hemp production. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine.

Data 188

Data Clinical Trials Chronic Pain Medicine 188

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The panel also took up a bill sponsored by Rep.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40